Inhibitors of Ocular Neovascularization: Promises and Potential Problems.

Discusses the prevention of vision loss caused by diabetic retinopathy and exudative age-related macular degeneration (ARMD). Impact of molecular medicine on the prevention of the condition; Limitations of conventional treatments; Potential for therapeutic intervention in vascular endothelial growth factor (VEGF); Details of therapeutic strategies used to address VEGF; Challenge presented by the potential side effects of necessary intraocular infections; Role of VEGF in neurological function; Potential benefits of drugs targeting VEGF.